According to Anixa Biosciences's latest financial reports the company's current EPS (TTM) is -$0.35. In 2022 the company made an earnings per share (EPS) of -$0.46 a decrease over its 2021 EPS that were of -$0.44.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.35 | -23.91% |
2022 | -$0.46 | 4.55% |
2021 | -$0.44 | -2.22% |
2020 | -$0.45 | -23.73% |
2019 | -$0.59 | -24.36% |
2018 | -$0.78 | 25.81% |
2017 | -$0.62 | 9.96% |
2016 | -$0.56 | 287.19% |
2015 | -$0.15 | -87.69% |
2014 | -$1.18 | 30% |
2013 | -$0.91 | 71.93% |
2012 | -$0.53 | -41.84% |
2011 | -$0.91 | 33.33% |
2010 | -$0.68 | -75% |
2009 | -$2.73 | 140% |
2008 | -$1.14 | -0% |
2007 | -$1.14 | -37.5% |
2006 | -$1.82 | 100% |
2005 | -$0.91 | -0% |
2004 | -$0.91 | -0% |
2003 | -$0.91 | -20% |
2002 | -$1.14 | -16.67% |
2001 | -$1.37 | -24.93% |
2000 | -$1.82 | -42.91% |
1999 | -$3.19 | 16.67% |
1998 | -$2.73 | 20% |
1997 | -$2.28 | -9.09% |
1996 | -$2.50 |